Prospective intra-individual comparison of the mpMRI versus 68Ga-PSMA11 PET/MRI in a blinded read to evaluate diagnostic accuracy in patients with prostate cancer
- Conditions
- Prostate CancerD011471
- Registration Number
- JPRN-jRCTs022220021
- Lead Sponsor
- Kojima Yoshiyuki
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Male
- Target Recruitment
- 152
1) Patients who have given written consent to participate in the study
2) Prostate cancer patients diagnosed with adenocarcinoma by prostate biopsy
3) Patients aged 40 or over at the time of registration
4) Untreated prostate cancer patients
5) Patients who are scheduled to undergo radical prostatectomy as curative treatment
1) Patients with obvious distant metastasis by CT /bone scintigraphy.
2) Patients who are ineligible for MRI examination, such as having a metal-containing medical device embedded in their body and claustrophobia.
3) Patients with other active cancers other than prostate cancer.
4) Patients with contrast medium allergy to gadolinium.
5) Patients who are judged by the principal investigator to be inappropriate for inclusion in the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Comparison of diagnostic accuracy in clinical T staging between 68Ga-PSMA-11 PET/MRI and mpMRI
- Secondary Outcome Measures
Name Time Method